vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Vroom, Inc. is the larger business by last-quarter revenue ($235.9M vs $158.6M, roughly 1.5× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -59.8%, a 131.0% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 12.9%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-108.8M).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
STOK vs VRM — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $235.9M |
| Net Profit | $112.9M | $-141.1M |
| Gross Margin | — | 12.3% |
| Operating Margin | 70.2% | -11.5% |
| Net Margin | 71.2% | -59.8% |
| Revenue YoY | 3661.1% | 12.9% |
| Net Profit YoY | 528.0% | -669.8% |
| EPS (diluted) | $1.90 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 25 | $158.6M | — | ||
| Q4 24 | $22.6M | — | ||
| Q4 23 | — | $235.9M | ||
| Q3 23 | — | $235.6M | ||
| Q2 23 | $-2.5M | $225.2M | ||
| Q1 23 | — | $196.5M | ||
| Q4 22 | — | $208.9M | ||
| Q3 22 | — | $340.8M |
| Q1 25 | $112.9M | — | ||
| Q4 24 | $-10.5M | — | ||
| Q4 23 | — | $-141.1M | ||
| Q3 23 | — | $-82.7M | ||
| Q2 23 | $-30.7M | $-66.0M | ||
| Q1 23 | — | $-74.7M | ||
| Q4 22 | — | $24.8M | ||
| Q3 22 | — | $-51.1M |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | 12.3% | ||
| Q3 23 | — | 20.4% | ||
| Q2 23 | — | 20.4% | ||
| Q1 23 | — | 19.8% | ||
| Q4 22 | — | 14.1% | ||
| Q3 22 | — | 19.8% |
| Q1 25 | 70.2% | — | ||
| Q4 24 | -60.4% | — | ||
| Q4 23 | — | -11.5% | ||
| Q3 23 | — | -18.0% | ||
| Q2 23 | 1340.7% | -23.4% | ||
| Q1 23 | — | -34.7% | ||
| Q4 22 | — | -37.2% | ||
| Q3 22 | — | -22.9% |
| Q1 25 | 71.2% | — | ||
| Q4 24 | -46.4% | — | ||
| Q4 23 | — | -59.8% | ||
| Q3 23 | — | -35.1% | ||
| Q2 23 | 1235.6% | -29.3% | ||
| Q1 23 | — | -38.0% | ||
| Q4 22 | — | 11.9% | ||
| Q3 22 | — | -15.0% |
| Q1 25 | $1.90 | — | ||
| Q4 24 | $-0.15 | — | ||
| Q4 23 | — | $-80.66 | ||
| Q3 23 | — | $-47.38 | ||
| Q2 23 | $-0.69 | $-37.97 | ||
| Q1 23 | — | $-43.16 | ||
| Q4 22 | — | — | ||
| Q3 22 | — | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $135.6M |
| Total DebtLower is stronger | — | $454.2M |
| Stockholders' EquityBook value | $350.1M | $127.7M |
| Total Assets | $406.9M | $1.5B |
| Debt / EquityLower = less leverage | — | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q1 25 | $274.8M | — | ||
| Q4 24 | $128.0M | — | ||
| Q4 23 | — | $135.6M | ||
| Q3 23 | — | $208.6M | ||
| Q2 23 | $192.1M | $237.9M | ||
| Q1 23 | — | $316.7M | ||
| Q4 22 | — | $398.9M | ||
| Q3 22 | — | $509.7M |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | $454.2M | ||
| Q3 23 | — | $521.4M | ||
| Q2 23 | — | $544.9M | ||
| Q1 23 | — | $554.7M | ||
| Q4 22 | — | $402.2M | ||
| Q3 22 | — | $607.8M |
| Q1 25 | $350.1M | — | ||
| Q4 24 | $229.0M | — | ||
| Q4 23 | — | $127.7M | ||
| Q3 23 | — | $263.6M | ||
| Q2 23 | $190.2M | $343.4M | ||
| Q1 23 | — | $407.1M | ||
| Q4 22 | — | $479.8M | ||
| Q3 22 | — | $445.1M |
| Q1 25 | $406.9M | — | ||
| Q4 24 | $271.6M | — | ||
| Q4 23 | — | $1.5B | ||
| Q3 23 | — | $1.6B | ||
| Q2 23 | $256.9M | $1.6B | ||
| Q1 23 | — | $1.7B | ||
| Q4 22 | — | $1.6B | ||
| Q3 22 | — | $1.8B |
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | 3.56× | ||
| Q3 23 | — | 1.98× | ||
| Q2 23 | — | 1.59× | ||
| Q1 23 | — | 1.36× | ||
| Q4 22 | — | 0.84× | ||
| Q3 22 | — | 1.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $-108.1M |
| Free Cash FlowOCF − Capex | $131.7M | $-108.8M |
| FCF MarginFCF / Revenue | 83.0% | -46.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.17× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 25 | $131.8M | — | ||
| Q4 24 | $-23.2M | — | ||
| Q4 23 | — | $-108.1M | ||
| Q3 23 | — | $-193.5M | ||
| Q2 23 | $-21.8M | $-147.1M | ||
| Q1 23 | — | $-85.0M | ||
| Q4 22 | — | $-86.0M | ||
| Q3 22 | — | $114.4M |
| Q1 25 | $131.7M | — | ||
| Q4 24 | $-23.2M | — | ||
| Q4 23 | — | $-108.8M | ||
| Q3 23 | — | $-194.2M | ||
| Q2 23 | $-22.6M | $-147.5M | ||
| Q1 23 | — | $-85.8M | ||
| Q4 22 | — | $-90.2M | ||
| Q3 22 | — | $110.5M |
| Q1 25 | 83.0% | — | ||
| Q4 24 | -102.7% | — | ||
| Q4 23 | — | -46.1% | ||
| Q3 23 | — | -82.4% | ||
| Q2 23 | 912.5% | -65.5% | ||
| Q1 23 | — | -43.7% | ||
| Q4 22 | — | -43.2% | ||
| Q3 22 | — | 32.4% |
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q4 23 | — | 0.3% | ||
| Q3 23 | — | 0.3% | ||
| Q2 23 | -33.8% | 0.2% | ||
| Q1 23 | — | 0.4% | ||
| Q4 22 | — | 2.0% | ||
| Q3 22 | — | 1.2% |
| Q1 25 | 1.17× | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q4 22 | — | -3.47× | ||
| Q3 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
